Scholarlink

Background <p>While VT ablation is increasingly recognized as effective, its real-world efficacy, risks, and outcomes require further investigation. This study aims to assess VT ablations in a real-world scenario using data from the German VIDEO registry.</p> Methods <p>We analyzed 801 ICD patients hospitalized with VT within the German VIDEO registry between 2018 and 2023. Among these, 145 patients (18%) underwent VT ablation. Characteristics and in-hospital outcomes were compared between patients with and without ablation.</p> Results <p>Patients (mean age 63 ± 14&#xa0;years, 19% female) selected for VT ablation had fewer comorbidities. The ablation group had lower rates of diabetes mellitus (16.6% vs. 24.7%, <i>p</i> = 0.04), chronic kidney disease (11.0% vs. 25.0%, <i>p</i> &lt; 0.01), and ischemic heart disease (55.9% vs. 68.1%, <i>p</i> &lt; 0.01). In-hospital outcomes differed between groups, with fewer ICU admissions (39.3% vs. 55.5%, <i>p</i> &lt; 0.01) and less need for mechanical ventilation (11.0% vs. 20.1%, <i>p</i> = 0.01) in the ablation group. Additionally, the ablation group experienced fewer serious arrhythmic events, including lower rates of ventricular fibrillation (8.3% vs. 17.2%, <i>p</i> &lt; 0.01) and cardiac arrest (9.7% vs. 19.1%, <i>p</i> &lt; 0.01) while in-hospital mortality did not differ significantly.</p> Conclusion <p>In this real-world registry, about 20% of VT patients underwent catheter ablation. Patients undergoing ablation had fewer comorbidities, indicating substantial selection. Observed differences in in-hospital outcomes likely reflect the combination of patient selection for ablation and treatment effects.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Real-world characteristics and management of ventricular tachycardias in ICD patients: Data from the VIDEO registry

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月24日

查看全文
  • Fabienne Kreimer,
  • Julian Wolfes,
  • Thomas Riemer,
  • Jochen Senges,
  • Christian Perings,
  • Roland Tilz,
  • Ibrahim Akin,
  • Christian Meyer,
  • Thomas Kleemann,
  • Malte Kuniss,
  • Daniel Steven,
  • Lars Eckardt

摘要

Background

While VT ablation is increasingly recognized as effective, its real-world efficacy, risks, and outcomes require further investigation. This study aims to assess VT ablations in a real-world scenario using data from the German VIDEO registry.

Methods

We analyzed 801 ICD patients hospitalized with VT within the German VIDEO registry between 2018 and 2023. Among these, 145 patients (18%) underwent VT ablation. Characteristics and in-hospital outcomes were compared between patients with and without ablation.

Results

Patients (mean age 63 ± 14 years, 19% female) selected for VT ablation had fewer comorbidities. The ablation group had lower rates of diabetes mellitus (16.6% vs. 24.7%, p = 0.04), chronic kidney disease (11.0% vs. 25.0%, p < 0.01), and ischemic heart disease (55.9% vs. 68.1%, p < 0.01). In-hospital outcomes differed between groups, with fewer ICU admissions (39.3% vs. 55.5%, p < 0.01) and less need for mechanical ventilation (11.0% vs. 20.1%, p = 0.01) in the ablation group. Additionally, the ablation group experienced fewer serious arrhythmic events, including lower rates of ventricular fibrillation (8.3% vs. 17.2%, p < 0.01) and cardiac arrest (9.7% vs. 19.1%, p < 0.01) while in-hospital mortality did not differ significantly.

Conclusion

In this real-world registry, about 20% of VT patients underwent catheter ablation. Patients undergoing ablation had fewer comorbidities, indicating substantial selection. Observed differences in in-hospital outcomes likely reflect the combination of patient selection for ablation and treatment effects.

Graphical abstract